Seeing the invisible: Reorienting cardiovascular risk prediction across the disease trajectory
Current risk equations miss many cardiovascular events in people classified as low risk. Prediction is simultaneously advancing on two axes: broadening predictors toward molecular omics, and expanding outcomes toward earlier subclinical atherosclerosis and later heart failure.